Clinical research studies
We currently support a number of clinical research studies, including:
- ALIOS: This is an international study is looking at Pharmokinetics and safety profile of single of an antiviral study drug in otherwise healthy term infants between 1-12 months with proven RSV bronchiolitis. The single ascending and multiple ascending dosage phases of the trial are now completed and analysis of results from all international centres are awaited.
- Regeneron Study: A Phase 3, Randomized, Double-blind, Placebo‑controlled Study Evaluating the Efficacy and Safety of a Human Monoclonal Antibody, REGN2222, for the Prevention of Medically Attended RSV Infection in Preterm Infants.
- SANAD II Trial: This is a national trial comparing newer vs. older antiepileptic medication
- Corticosteroid induced cataract in childhood steroid sensitive Nephrotic syndrome